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Background: Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD). We have shown that left 
ventricular (LV) ejection fraction (EF) is a major determinant of survival in ESRD. The prognostic importance of LV dyssynchrony has not been well 
studied.
Methods: We measured indices of LV mechanical dyssynchrony by automated analysis of gated SPECT myocardial perfusion imaging in ESRD 
patients evaluated for transplantation at our institution (2000-2004) who had coronary angiography. All-cause mortality data was prospectively 
collected and verified against the social security death index database.
Results: The study population consisted of 144 ESRD patients (53±9y, 35% female, 63% diabetes mellitus, LVEF 48±12%) who were followed up 
for 41±28 months during which 55 (38%) died prior to renal transplantation. The median phase bandwidth (BW) was 62° (range 22-264°) and 
standard deviation (SD) was 23° (range 4-71°). Patients with a BW above the median had worse survival (log-rank P=0.017) and there was a trend 
towards worse survival in those with a SD above the median (log-rank P=0.096). 2-year mortality was higher in those with BW≥62° in the entire 
cohort, and in the subset of patients with normal LVEF, coronary artery disease by angiography, and LV hypertrophy by electrocardiography (Table).
Conclusions: LV mechanical dyssynchrony by phase analysis is a predictor of mortality in patients with ESRD and may have a role in risk-stratifying 
patients with normal LVEF.
BW<62° BW≥62° p-value
Entire cohort 4/68 (6%) 17/76 (22%) 0.008
LVEF≥50% 2/48 (4%) 4/17(24%) 0.02
LVEF<50% 2/15 (13%) 11/57 (19%) 0.5
No CAD 1/22 (5%) 2/16 (13%) 0.6
CAD 3/44 (7%) 15/60 (25%) 0.018
No LVH 3/36 (8%) 7/41 (17%) 0.3
LVH 1/32 (3%) 10/35 (29%) 0.007
CAD = coronary artery disease, 
LVH = left ventricular hypertrophy
